NCT06078436Recruiting
Pulmonary Artery Catheterization and Carvedilol Early Initiation in Cardiogenic SHOCK Due to HFrEF
Pulmonary Artery Catheterization and Carvedilol Early Initiation in Cardiogenic SHOCK Caused by Heart Failure With Reduced Ejection Fraction
Source: ClinicalTrials.gov · Last updated 5 Jan 2024 · Not updated for over 12 months - ask the site whether it is still open
Brief summary (registry, in English)
This study aims to compare the impact of hemodynamic monitoring using pulmonary artery catheter (PAC) on survival and inotropic agent reduction in patients with cardiogenic shock caused by heart failure with reduced ejection fraction (HFrEF). The investigators also intend to compare the difference in long-term survival rates among patients who have recovered from cardiogenic shock due to HFrEF, based on the timing of initiation of beta-blocker treatment.
- Status (registry)
- Recruiting
- Study type
- Interventional
- Enrollment
- 160 (estimated)
- First submitted
- 20 Sept 2023
- Start date
- Jan 2024
- Primary completion date
- Sept 2027
- Lead sponsor
- Min-Seok Kim
- Diseases
- Heart failure
- NCT number
- NCT06078436
What you commit to
- Study type: Interventional
- Planned participants: 160
- From Jan 2024 to the primary completion date, Sept 2027
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Patients currently undergoing de-sensitization therapy
Other illness
- Patients with acute coronary syndrome
- Patients with severe valvular heart disease requiring emergent percutaneous procedures or surgery
- Known hypersensitivity to beta-blockers
- Patients with a history of bronchospasm or asthma
- Patients with sick sinus syndrome, including sinoatrial block
Other
- Unwilling or unable to obtain informed consent by the participant or substitute decision maker
- Patients with mechanical circulatory support at the time of screening
- Patients with bradycardia or second or third-degree atrioventricular block
- Patients with untreated pheochromocytoma
- Patients who are currently pregnant, postpartum period within 30 days or breast-feeding
Who the study is looking for
- Adults age 19 and above ( no age limit for elderly )
- Patients with cardiogenic shock requiring intensive care monitoring in ICU
- Patients eligible for oral medication administration
- Patients who have provided research participation consent through a written informed consent form
Age in the registry: 19 years to - · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Asan Medical Center Coordinator of this site? Confirm its status | Seoul | South Korea | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.